Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Semaglutide and tirzepatide are FDA-approved with extensive clinical trial data showing average 15-20% body weight loss, improvements in cardiovascular health markers, reduction in obesity-related disease risk, and excellent safety profile with proper medical supervision
For a 3-month program, you receive three months of medication at once
10.7717/peerj.1039 22
The existence of multiple competitors is actually good for patients
It also uniquely slashed inflammation, as measured by high-sensitivity C-reactive protein, by about 43% compared to placebo Another study found that activating GLP-1 receptors in the brain dramatically lowered inflammation in mice, cutting the surge of TNF- and easing inflammation-related harm during sepsis
US$ 22.54
US$ 20.85
US$ 27.04
